From: Comparing the efficacy of a web-assisted calprotectin-based treatment algorithm (IBD-live) with usual practices in teenagers with inflammatory bowel disease: study protocol for a randomized controlled trial
Physician Global Assessment
PCDAI [7]
shPCDAI [14, 38]
PUCAI [8]
Remission
<10
Mild activity
10-30
10-25
10-34
Moderate activity
≥30
26-40
35-64
Severe activity
>40
≥65